Back
NexgenRx Vs. Extendicare Industry Stock Comparison
Buy
68
NXG.V
NexgenRx
Last Price:
$0.37
Seasonality Move:
0.61%
Buy
61
EXE.TO
Extendicare
Last Price:
$12.67
Seasonality Move:
-0.79%
Buy
61
Extendicare (EXE.TO)
is a Buy
Is Extendicare a Buy, Sell or Hold?
-
The current Extendicare [EXE.TO] share price is $12.66. The Score for EXE.TO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
EXE.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NXG.V Stock Price Chart
EXE.TO Stock Price Chart
What is Extendicare's stock price today?
-
The Extendicare share price today is $12.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXE.TO is experiencing slight buying pressure.
NXG.V Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 53.42 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.37) | Sell |
Bollinger Bands (100): | (0.26 - 0.34) | Buy |
EXE.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.18 | Buy |
Relative Strength Index (14 RSI): | 42.4 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.53 - 13.55) | Sell |
Bollinger Bands (100): | (12.89 - 14.23) | Sell |
NXG.V Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.35 | Buy |
20-day SMA: | 0.36 | Sell |
50-day SMA: | 0.32 | Buy |
200-day SMA: | 0.29 | Buy |
8-day EMA: | 0.27 | Buy |
20-day EMA: | 0.16 | Buy |
50-day EMA: | 0.07 | Buy |
200-day EMA: | 0.02 | Buy |
EXE.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.5 | Buy |
20-day SMA: | 12.86 | Sell |
50-day SMA: | 13.62 | Sell |
200-day SMA: | 12.02 | Buy |
8-day EMA: | 12.49 | Buy |
20-day EMA: | 10.98 | Buy |
50-day EMA: | 7.04 | Buy |
200-day EMA: | 2.33 | Buy |
NexgenRx Earnings Growth & NXG.V Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Extendicare Earnings Growth & EXE.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.10 per share.
NexgenRx Technical Analysis
Jul 23 | Jul 24 | Jul 25 | Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Extendicare Technical Analysis
Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 5 | Aug 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
22 | 23 | 24 | 25 | 29 | 30 | 31 | 01 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |